Auguste-Louis Loubatières was a French endocrinologist known for his contributions to the development of sulfonamide antidiabetic medications. Born on December 28, 1912, in Agde, he demonstrated the hypoglycemic effects of certain antibacterials and established the necessity of a pancreas for these effects in 1942. He became a free member of the Academy of Sciences in 1967. The lycée in Agde was renamed in his honor. He passed away on January 9, 1977, in Montpellier, where he is also buried.
Zodiac Sign (Western)
Sunsign, Tropical Zodiac
Zodiac Sign (Vedic)
Moonsign, Sidereal Zodiac
Age (Today)
Your next birthday is 325 days away.
Death Anniversary
Next death anniversary is 27 days away.
Death Date
Place of Birth
Time Zone - Europe/Paris (0:0 W)
Chinese Zodiac Sign
Birth Number
Life Path Number
Name Number (Chaldean)
Name Number (Pythagorean)
December 28, 1912 Facts
Generation Group
Auguste-Louis Loubatières belongs to the GI Generation group.
Place of Birth: Agde
Place of Death: Montpellier
Occupation: physician
Awards Received: Member of the Academy of Sciences (1967)
Astrology Analysis
Ephemeris for December 28, 1912
Note: Moon position is location and time sensitive.| Planet | Position (Tropical, Western) | Transits on December 28, 2024 | Secondary Progressions for December 28, 2024 |
|---|---|---|---|
| Sun | 6 Capricorn 25 | 7 Capricorn 15 | 28 Aries 49 |
| Moon | 5 Virgo 30 | 8 Sagittarius 22 | 9 Libra 54 |
| Mercury | 14 Sagittarius 7 | 15 Sagittarius 33 | 2 Aries 34 |
| Venus | 18 Aquarius 35 | 23 Aquarius 55 | 7 Taurus 39 |
| Mars | 20 Sagittarius 21 | 3 Leo 0 | 15 Pisces 40 |
| Jupiter | 28 Sagittarius 34 | 13 Gemini 35 | 17 Capricorn 9 |
| Saturn | 28 Taurus 46 | 14 Pisces 12 | 3 Gemini 8 |
| Uranus | 1 Aquarius 57 | 23 Taurus 44 | 7 Aquarius 18 |
| Neptune | 25 Cancer 7 | 27 Pisces 15 | 23 Cancer 17 |
| Pluto | 28 Gemini 53 | 0 Aquarius 57 | 28 Gemini 16 |
| Rahu | 7 Aries 54 | 1 Aries 40 | 1 Aries 59 |
| Ketu | 7 Libra 54 | 1 Libra 40 | 1 Libra 59 |
Chandra Kundali (Equal House, North Indian Diamond Chart)
